The primary advantages of GLP-1RAs lie in glucose reduction, cardiorenal benefits, and amelioration of metabolic syndrome, all of which are substantiated by a plethora of evidence-based studies [1,2,3,4]
Intramuscular and intravenous delivery bypasses the gastrointestinal tract, achieving significantly higher bioavailability than oral supplementation, making injectable micronutrients a clinically effective option for patients with confirmed or suspected deficiency, malabsorption conditions, or chronic illness
In animal studies this translates to reported support for the recruitment of reparative cells across multiple tissue types simultaneously a whole-system mobility effect rather than a single-site one
This muscle loss occurs because GLP-1 medications slow gastric emptying and suppress appetite
This keeps blood sugar levels in a healthy range
So, these impressive results are even more impressive when you consider: The incredible retention rate of 82% , i.e